Haruka Yokota
R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, Japan
- Papers in database
- 4
- Primary author
- 2 papers
- Years active
- 2021 – 2025
Papers (4)
- 2025Primary authorCoculture of Bifidobacterium bifidum G9-1 With Butyrate-Producing Bacteria Promotes Butyrate Production.10.1111/1348-0421.13224
- 2025Primary authorBifidobacterium bifidum G9-1 Survives in the Intestinal Environment and Influences the Gut Microbiota Despite the Presence of Antimicrobials.10.1111/1348-0421.13230
- 2022Correction: Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis.10.1371/journal.pone.0267927
- 2021Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis10.1371/journal.pone.0248584